Business overview
TrustScore Analysis
Our preliminary analysis has revealed key insights about CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE's performance and market presence. Here's a summary of our findings:
Strengths Identified
Areas of Concern
- Is relatively new
- No employer brand presence on career platforms
- No official business profile found on major search engines
- May not have contact information online
How your TrustScore is determined
Corporate Information
UEN
53461076E
Entity Type
Sole Proprietorship/ Partnership
Entity Status
Live
ACRA Registration Date
05 Jan 2023
UEN Issue Date
05 Jan 2023
No. of Officers
1
Business Constitution
Sole-Proprietor
Primary Business Activity
Research and experimental development on medical science
SSIC Code: 72106
Secondary Business Activity
BRINGING TOGETHER CARDIOVASCULAR RESEARCH & INNOVATION CAPABILITIES IN SG
CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE's Latest Blogs
Read more about thought leadership articles, industry insights, and official updates directly from CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE's team.
No company blog posts yet
Once posts are published, we will feature the freshest stories from CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE here.
Profile Activity for CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
Analytics and engagement metrics from recent Scam.SG visitor traffic patterns and profile interactions over the past 14 days.
Steady
Comparable to other Research And Experimental Development On Medical Science companies
Public Preview of CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
This is only a preview of the TrustScore results for CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE, showcasing a few facets of its business that we have analysed.
Foundational Stage
A young brand or company in the early stage of organisation structures, framework, processes, workflow, systems.
- Defining Core Identity: CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE is likely still defining its mission, vision and values.
- Building Awareness: Working to establish recognition among its target audience and identifying opportunities in the research and experimental development on medical science sector.
- Limited Resources: Often operating with a small team, budget, or customer base. May not yet have a strong social media presence or widespread advertising.
- Focus on Differentiation: Still trying to carve out a unique position in the market, or have a unique selling proposition. They are gathering feedback and iterating on their offerings.
- These potential brands often represent innovation and creativity.
- They often bring fresh ideas to the market and have the opportunity to grow into influential players if they successfully establish their identity and connect with their audience.
The company's address is shared by several other companies. While this is common for business centers and co-working spaces, it may affect the perceived exclusivity of the business location. CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE is relatively new. Companies that have been established for a longer period of time are generally considered more reliable and trustworthy.
CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE has no presence on career platforms and provides no public information about its work environment or employee satisfaction. This lack of transparency may indicate less focus on employee well-being or difficulty in attracting talent, potentially impacting CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE's long-term success.
The company is not on the MAS Enforcement List, which is a positive indicator of its compliance with financial regulations. The company is not blacklisted by CaseTrust, which is a positive indicator of its credibility.
The company has no official business profile on major search engines. This absence makes it difficult for potential customers to verify the company's legitimacy or get in touch, potentially raising suspicions about its credibility. CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE may not have accessible contact information online, which dilutes engagement and credibility.
Unlock Complete Analysis
Get access to all metrics and detailed risk assessments for CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
TrustScore Last Scanned:
14 Dec 2025CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE Job Openings
Explore available job positions and career opportunities currently offered by CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE.
No Job Openings Available
CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE doesn't have any active job listings at the moment. Check back later for new opportunities.
Related Business Entities to CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
Explore Singapore-registered businesses that share similar characteristics with CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE, including companies with related names, operating in the same industry sectors, or located in nearby geographical areas.
Similar Business Names
Companies with names similar to CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
Nearby Businesses
Businesses located in ROCHESTER PARK, Singapore 139234
ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE
CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION, SINGAPORE PTE. LTD.
DATA4ECO HOLDINGS PTE. LTD.
EDPR SUNSEAP KOREA HOLDINGS PTE. LTD.
GLAXOCHEM PTE LTD
Similar Principal Activity
Companies with the same primary SSIC code: 72106
OSSEOLABS TECHNOLOGIES PTE. LTD.
POLYMED BIOMEDICINE (SINGAPORE) PRIVATE LIMITED
SYNAPTIX TECHNOLOGY PTE. LTD.
CIRRUS THERAPEUTICS PTE. LTD.
NEXT AND BIO SINGAPORE PTE. LTD.
Frequently Asked Questions About CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
Common questions and answers to help you learn more about CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE
CARDIOVASCULAR DISEASE NATIONAL COLLABORATIVE ENTERPRISE has been in operation for 2 years since its incorporation in 5 January 2023 based on ACRA registration date. The business is registered with ACRA (Accounting and Corporate Regulatory Authority) under UEN 53461076E.
Suggested reads for this industry
Hand-picked scam prevention resources relevant to Research and experimental development on medical science
Join the Scam.SG community
Share your experience to help others make confident decisions. Follow us for the latest scam prevention tips and community updates.